NCCN Practice Guidelines for Prostate Cancer.

R. R. Bahnson, G. E. Hanks, R. P. Huben, P. Kantoff, J. M. Kozlowski, M. Kuettel, P. H. Lange, C. Logothetis, J. M. Pow-Sang, M. Roach, H. Sandler, P. T. Scardino, R. J. Taylor, D. A. Urban, P. C. Walsh, T. G. Wilson

Research output: Contribution to journalArticle

Abstract

Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced cancers. Further technical improvements in radiotherapy and alternative local modalities, such as cryoablation, are also likely, and will bring even more options for local control. It is certain these guidelines will continue to evolve.

Original languageEnglish (US)
Pages (from-to)111-119
Number of pages9
JournalOncology (Williston Park, N.Y.)
Volume14
Issue number11 A
StatePublished - Nov 2000

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'NCCN Practice Guidelines for Prostate Cancer.'. Together they form a unique fingerprint.

  • Cite this

    Bahnson, R. R., Hanks, G. E., Huben, R. P., Kantoff, P., Kozlowski, J. M., Kuettel, M., Lange, P. H., Logothetis, C., Pow-Sang, J. M., Roach, M., Sandler, H., Scardino, P. T., Taylor, R. J., Urban, D. A., Walsh, P. C., & Wilson, T. G. (2000). NCCN Practice Guidelines for Prostate Cancer. Oncology (Williston Park, N.Y.), 14(11 A), 111-119.